Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring tensile strength	COL4A3 COL4A4 COL10A1	5.42e-05	46	32	3	GO:0030020
GeneOntologyMolecularFunction	transcription coactivator activity	BCL9L TCF20 BCL9 ARID1A CREBBP	1.12e-04	303	32	5	GO:0003713
GeneOntologyMolecularFunction	chromatin binding	ANKRD17 ARID1A RBMXL1 CREBBP AHDC1 RBMX CRTC2	1.38e-04	739	32	7	GO:0003682
GeneOntologyMolecularFunction	cAMP response element binding protein binding	CREBBP CRTC2	1.63e-04	12	32	2	GO:0008140
GeneOntologyMolecularFunction	transcription coregulator activity	BCL9L TCF20 BCL9 ARID1A CREBBP SF1	2.35e-04	562	32	6	GO:0003712
GeneOntologyMolecularFunction	molecular adaptor activity	COL4A4 BCL9L TCF20 BCL9 ARID1A CREBBP AHDC1 SF1	1.07e-03	1356	32	8	GO:0060090
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL4A3 COL4A4 COL10A1	3.33e-03	188	32	3	GO:0005201
GeneOntologyBiologicalProcess	positive regulation of mRNA splicing, via spliceosome	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F	2.21e-15	44	32	8	GO:0048026
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	3.69e-15	129	32	10	GO:0048024
GeneOntologyBiologicalProcess	positive regulation of mRNA processing	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F	5.60e-15	49	32	8	GO:0050685
GeneOntologyBiologicalProcess	regulation of mRNA processing	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	2.91e-14	158	32	10	GO:0050684
GeneOntologyBiologicalProcess	positive regulation of RNA splicing	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F	4.74e-14	63	32	8	GO:0033120
GeneOntologyBiologicalProcess	regulation of RNA splicing	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	4.44e-13	207	32	10	GO:0043484
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	1.01e-10	358	32	10	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	1.01e-10	358	32	10	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	1.12e-10	362	32	10	GO:0000375
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	7.98e-10	443	32	10	GO:1903311
GeneOntologyBiologicalProcess	RNA splicing	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	2.66e-09	502	32	10	GO:0008380
GeneOntologyBiologicalProcess	positive regulation of mRNA metabolic process	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F	4.50e-09	259	32	8	GO:1903313
GeneOntologyBiologicalProcess	mRNA processing	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	6.49e-09	551	32	10	GO:0006397
GeneOntologyBiologicalProcess	mRNA metabolic process	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	7.59e-07	917	32	10	GO:0016071
GeneOntologyBiologicalProcess	male gonad development	RBMY1D RBMY1B RBMY1E SF1 RBMY1A1	6.20e-06	171	32	5	GO:0008584
GeneOntologyBiologicalProcess	development of primary male sexual characteristics	RBMY1D RBMY1B RBMY1E SF1 RBMY1A1	6.38e-06	172	32	5	GO:0046546
GeneOntologyBiologicalProcess	male sex differentiation	RBMY1D RBMY1B RBMY1E SF1 RBMY1A1	1.30e-05	199	32	5	GO:0046661
GeneOntologyBiologicalProcess	positive regulation of gene expression	RBMY1D RBMY1B RBMY1E ARID1A RBMXL1 CREBBP RBMX RBMY1A1 RBMY1C RBMY1F	4.30e-05	1446	32	10	GO:0010628
GeneOntologyBiologicalProcess	RNA processing	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	5.88e-05	1500	32	10	GO:0006396
GeneOntologyBiologicalProcess	gonad development	RBMY1D RBMY1B RBMY1E SF1 RBMY1A1	8.09e-05	292	32	5	GO:0008406
GeneOntologyBiologicalProcess	development of primary sexual characteristics	RBMY1D RBMY1B RBMY1E SF1 RBMY1A1	8.76e-05	297	32	5	GO:0045137
GeneOntologyBiologicalProcess	regulation of alternative mRNA splicing, via spliceosome	RBMX RBMY1A1 HNRNPL	1.04e-04	59	32	3	GO:0000381
GeneOntologyBiologicalProcess	glomerular basement membrane development	COL4A3 COL4A4	1.04e-04	10	32	2	GO:0032836
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	ETV5 BCL9L SSBP4 TCF20 BCL9 RBMXL1 CREBBP RBMX CRTC2	1.90e-04	1390	32	9	GO:0045944
GeneOntologyBiologicalProcess	sex differentiation	RBMY1D RBMY1B RBMY1E SF1 RBMY1A1	1.94e-04	352	32	5	GO:0007548
GeneOntologyBiologicalProcess	hematopoietic progenitor cell differentiation	RBMY1D RBMY1B RBMY1E RBMY1A1	2.35e-04	197	32	4	GO:0002244
GeneOntologyBiologicalProcess	alternative mRNA splicing, via spliceosome	RBMX RBMY1A1 HNRNPL	2.48e-04	79	32	3	GO:0000380
GeneOntologyBiologicalProcess	reproductive structure development	RBMY1D RBMY1B RBMY1E SF1 RBMY1A1	2.87e-04	383	32	5	GO:0048608
GeneOntologyBiologicalProcess	reproductive system development	RBMY1D RBMY1B RBMY1E SF1 RBMY1A1	3.04e-04	388	32	5	GO:0061458
GeneOntologyBiologicalProcess	positive regulation of CREB transcription factor activity	CREBBP CRTC2	3.51e-04	18	32	2	GO:0032793
GeneOntologyBiologicalProcess	stem cell population maintenance	BCL9L BCL9 ARID1A CREBBP	4.75e-04	237	32	4	GO:0019827
GeneOntologyBiologicalProcess	maintenance of cell number	BCL9L BCL9 ARID1A CREBBP	5.13e-04	242	32	4	GO:0098727
GeneOntologyBiologicalProcess	myoblast differentiation	BCL9L BCL9 ARID1A	1.21e-03	136	32	3	GO:0045445
GeneOntologyCellularComponent	spliceosomal complex	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C RBMY1F	3.39e-11	215	33	9	GO:0005681
GeneOntologyCellularComponent	nuclear protein-containing complex	RBMY1D RBMY1B RBMY1E BCL9L BCL9 ARID1A RBMXL1 CREBBP SF1 RBMX RBMY1A1 RBMY1C RBMY1F	6.87e-08	1377	33	13	GO:0140513
GeneOntologyCellularComponent	network-forming collagen trimer	COL4A3 COL4A4 COL10A1	2.00e-07	8	33	3	GO:0098642
GeneOntologyCellularComponent	collagen network	COL4A3 COL4A4 COL10A1	2.00e-07	8	33	3	GO:0098645
GeneOntologyCellularComponent	male germ cell nucleus	RBMY1D RBMY1B RBMY1E ANKRD17 RBMY1A1	2.27e-07	86	33	5	GO:0001673
GeneOntologyCellularComponent	germ cell nucleus	RBMY1D RBMY1B RBMY1E ANKRD17 RBMY1A1	8.88e-07	113	33	5	GO:0043073
GeneOntologyCellularComponent	complex of collagen trimers	COL4A3 COL4A4 COL10A1	4.68e-06	21	33	3	GO:0098644
GeneOntologyCellularComponent	ribonucleoprotein complex	RBMY1D RBMY1B RBMY1E RBMXL1 SF1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	9.84e-06	1194	33	10	GO:1990904
GeneOntologyCellularComponent	supraspliceosomal complex	RBMXL1 RBMX	1.45e-05	4	33	2	GO:0044530
GeneOntologyCellularComponent	collagen type IV trimer	COL4A3 COL4A4	3.61e-05	6	33	2	GO:0005587
GeneOntologyCellularComponent	basement membrane collagen trimer	COL4A3 COL4A4	6.73e-05	8	33	2	GO:0098651
GeneOntologyCellularComponent	beta-catenin-TCF complex	BCL9L BCL9	1.86e-04	13	33	2	GO:1990907
GeneOntologyCellularComponent	collagen trimer	COL4A3 COL4A4 COL10A1	3.59e-04	88	33	3	GO:0005581
GeneOntologyCellularComponent	chromatin	ETV5 ANKRD17 NKX1-1 ARID1A CREBBP RBMX HNRNPL	7.35e-03	1480	33	7	GO:0000785
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	BCL9L BCL9 CREBBP	8.91e-03	272	33	3	GO:0090575
HumanPheno	Glomerular basement membrane lamellation	COL4A3 COL4A4	1.80e-05	3	13	2	HP:0030034
HumanPheno	Thin glomerular basement membrane	COL4A3 COL4A4	1.80e-05	3	13	2	HP:0012577
MousePheno	pale yolk sac	BCL9L ANKRD17 ARID1A CREBBP	1.96e-05	110	21	4	MP:0001722
Domain	RBM1CTR	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1F	1.34e-19	8	31	7	PF08081
Domain	RBM1CTR	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1F	1.34e-19	8	31	7	IPR012604
Domain	RRM_1	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 HNRNPL RBMY1F	1.31e-09	208	31	8	PF00076
Domain	RRM	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 HNRNPL RBMY1F	1.83e-09	217	31	8	SM00360
Domain	RRM_dom	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 HNRNPL RBMY1F	2.61e-09	227	31	8	IPR000504
Domain	RRM	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 HNRNPL RBMY1F	2.89e-09	230	31	8	PS50102
Domain	Nucleotide-bd_a/b_plait	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 HNRNPL RBMY1F	7.13e-09	258	31	8	IPR012677
Domain	-	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX HNRNPL RBMY1F	1.20e-07	244	31	7	3.30.70.330
Domain	BCL9_beta-catenin-bd_dom	BCL9L BCL9	2.67e-06	2	31	2	IPR024670
Domain	BCL9	BCL9L BCL9	2.67e-06	2	31	2	PF11502
Domain	Bcl-9	BCL9L BCL9	2.67e-06	2	31	2	IPR015668
Domain	C4	COL4A3 COL4A4	3.98e-05	6	31	2	SM00111
Domain	-	COL4A3 COL4A4	3.98e-05	6	31	2	2.170.240.10
Domain	Collagen_VI_NC	COL4A3 COL4A4	3.98e-05	6	31	2	IPR001442
Domain	NC1_IV	COL4A3 COL4A4	3.98e-05	6	31	2	PS51403
Domain	C4	COL4A3 COL4A4	3.98e-05	6	31	2	PF01413
Domain	Collagen	COL4A3 COL4A4 COL10A1	3.73e-04	85	31	3	PF01391
Domain	Collagen	COL4A3 COL4A4 COL10A1	3.73e-04	85	31	3	IPR008160
Domain	RRM_dom_euk	RBMXL1 RBMX	6.60e-04	23	31	2	IPR003954
Domain	RRM_1	RBMXL1 RBMX	6.60e-04	23	31	2	SM00361
Domain	KH_1	ANKRD17 SF1	1.81e-03	38	31	2	PF00013
Domain	-	ANKRD17 SF1	1.90e-03	39	31	2	3.30.1370.10
Domain	KH	ANKRD17 SF1	2.00e-03	40	31	2	SM00322
Domain	KH_dom	ANKRD17 SF1	2.00e-03	40	31	2	IPR004087
Domain	KH_TYPE_1	ANKRD17 SF1	2.20e-03	42	31	2	PS50084
Domain	KH_dom_type_1	ANKRD17 SF1	2.42e-03	44	31	2	IPR004088
Domain	PHD	DIDO1 TCF20	9.54e-03	89	31	2	SM00249
Domain	Znf_PHD	DIDO1 TCF20	9.96e-03	91	31	2	IPR001965
Domain	ZF_PHD_2	DIDO1 TCF20	1.08e-02	95	31	2	PS50016
Domain	ZF_PHD_1	DIDO1 TCF20	1.10e-02	96	31	2	PS01359
Domain	CTDL_fold	COL4A3 COL4A4	1.36e-02	107	31	2	IPR016187
Pathway	WP_MRNA_PROCESSING	RBMY1D RBMY1B RBMY1E COL4A3 RBMXL1 RBMX RBMY1A1 HNRNPL	6.91e-07	451	25	8	MM15946
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	COL4A3 COL4A4 COL10A1	2.36e-05	32	25	3	MM14924
Pathway	REACTOME_COLLAGEN_CHAIN_TRIMERIZATION	COL4A3 COL4A4 COL10A1	5.02e-05	41	25	3	MM15538
Pathway	REACTOME_COLLAGEN_CHAIN_TRIMERIZATION	COL4A3 COL4A4 COL10A1	6.22e-05	44	25	3	M27812
Pathway	PID_SYNDECAN_1_PATHWAY	COL4A3 COL4A4 COL10A1	7.11e-05	46	25	3	M198
Pathway	REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	COL4A3 COL4A4 COL10A1	9.14e-05	50	25	3	MM14796
Pathway	REACTOME_COLLAGEN_DEGRADATION	COL4A3 COL4A4 COL10A1	1.09e-04	53	25	3	MM14566
Pathway	BIOCARTA_NPP1_PATHWAY	COL4A3 COL4A4	1.35e-04	10	25	2	M22040
Pathway	BIOCARTA_NPP1_PATHWAY	COL4A3 COL4A4	1.35e-04	10	25	2	MM1560
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	COL4A3 COL4A4 COL10A1	1.50e-04	59	25	3	M27218
Pathway	BIOCARTA_VITCB_PATHWAY	COL4A3 COL4A4	1.64e-04	11	25	2	M15422
Pathway	REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	COL4A3 COL4A4 COL10A1	1.66e-04	61	25	3	M27103
Pathway	REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	COL4A3 COL4A4 COL10A1	1.66e-04	61	25	3	MM14637
Pathway	REACTOME_COLLAGEN_DEGRADATION	COL4A3 COL4A4 COL10A1	1.91e-04	64	25	3	M26953
Pathway	BIOCARTA_VITCB_PATHWAY	COL4A3 COL4A4	1.97e-04	12	25	2	MM1526
Pathway	REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	COL4A3 COL4A4 COL10A1	2.19e-04	67	25	3	M26999
Pathway	BIOCARTA_ACE2_PATHWAY	COL4A3 COL4A4	2.33e-04	13	25	2	MM1347
Pathway	BIOCARTA_ACE2_PATHWAY	COL4A3 COL4A4	2.33e-04	13	25	2	M12950
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	COL4A3 COL4A4	2.71e-04	14	25	2	MM1458
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	COL4A3 COL4A4	2.71e-04	14	25	2	M6487
Pathway	PID_AVB3_INTEGRIN_PATHWAY	COL4A3 COL4A4 COL10A1	2.94e-04	74	25	3	M160
Pathway	REACTOME_LAMININ_INTERACTIONS	COL4A3 COL4A4	3.13e-04	15	25	2	MM14922
Pathway	REACTOME_ANCHORING_FIBRIL_FORMATION	COL4A3 COL4A4	3.13e-04	15	25	2	M27161
Pathway	REACTOME_COLLAGEN_FORMATION	COL4A3 COL4A4 COL10A1	3.18e-04	76	25	3	MM14573
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL4A3 COL4A4 COL10A1	4.42e-04	85	25	3	M16441
Pathway	REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	COL4A3 COL4A4	4.54e-04	18	25	2	M27164
Pathway	REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	COL4A3 COL4A4	4.54e-04	18	25	2	MM14882
Pathway	REACTOME_COLLAGEN_FORMATION	COL4A3 COL4A4 COL10A1	5.23e-04	90	25	3	M631
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	BCL9L BCL9 CREBBP	5.40e-04	91	25	3	M27101
Pathway	BIOCARTA_AMI_PATHWAY	COL4A3 COL4A4	5.63e-04	20	25	2	M15394
Pathway	REACTOME_NCAM1_INTERACTIONS	COL4A3 COL4A4	5.63e-04	20	25	2	MM15061
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A CREBBP	6.82e-04	22	25	2	MM1370
Pathway	BIOCARTA_INTRINSIC_PATHWAY	COL4A3 COL4A4	7.47e-04	23	25	2	M15997
Pathway	BIOCARTA_INTRINSIC_PATHWAY	COL4A3 COL4A4	7.47e-04	23	25	2	MM1427
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A CREBBP	8.14e-04	24	25	2	M13404
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	BCL9L BCL9	9.56e-04	26	25	2	MM14793
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL4A3 COL4A4 COL10A1	1.04e-03	114	25	3	MM14571
Pathway	REACTOME_LAMININ_INTERACTIONS	COL4A3 COL4A4	1.27e-03	30	25	2	M27216
Pathway	PID_IL12_STAT4_PATHWAY	ETV5 CREBBP	1.45e-03	32	25	2	M290
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL4A3 COL4A4 COL10A1	1.88e-03	140	25	3	M587
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL4A3 COL4A4	2.04e-03	38	25	2	MM14969
Pathway	PID_FOXM1_PATHWAY	ETV5 CREBBP	2.26e-03	40	25	2	M176
Pathway	REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX	BCL9L BCL9	2.49e-03	42	25	2	M27272
Pathway	REACTOME_NCAM1_INTERACTIONS	COL4A3 COL4A4	2.49e-03	42	25	2	M7169
Pathway	PID_INTEGRIN3_PATHWAY	COL4A3 COL4A4	2.61e-03	43	25	2	M53
Pathway	WP_NEPHROTIC_SYNDROME	COL4A3 COL4A4	2.85e-03	45	25	2	M39864
Pathway	REACTOME_HEME_SIGNALING	CREBBP CRTC2	3.37e-03	49	25	2	M41832
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	CREBBP CRTC2	4.23e-03	55	25	2	M27145
Pathway	REACTOME_SIGNALING_BY_PDGF	COL4A3 COL4A4	4.54e-03	57	25	2	MM14713
Pathway	REACTOME_SIGNALING_BY_PDGF	COL4A3 COL4A4	4.70e-03	58	25	2	M2049
Pathway	REACTOME_MRNA_SPLICING	SF1 RBMX HNRNPL	5.21e-03	201	25	3	MM15411
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL4A3 COL4A4	5.52e-03	63	25	2	M11187
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	ARID1A CREBBP	5.87e-03	65	25	2	M39682
Pathway	PID_INTEGRIN1_PATHWAY	COL4A3 COL4A4	6.04e-03	66	25	2	M18
Pathway	REACTOME_MRNA_SPLICING	SF1 RBMX HNRNPL	6.04e-03	212	25	3	M14033
Pathway	REACTOME_CIRCADIAN_CLOCK	CREBBP CRTC2	6.77e-03	70	25	2	M938
Pubmed	A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	3.15e-18	7	33	6	8269511
Pubmed	Structure and organization of the RBMY genes on the human Y chromosome: transposition and amplification of an ancestral autosomal hnRNPG gene.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	4.15e-16	12	33	6	9598316
Pubmed	RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	3.36e-15	6	33	5	15184870
Pubmed	Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	1.17e-14	7	33	5	8875892
Pubmed	RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing.	RBMY1B RBMX RBMY1A1 RBMY1C RBMY1F	7.17e-13	13	33	5	10749975
Pubmed	Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome.	RBMY1D RBMY1B RBMY1E RBMX RBMY1A1	1.67e-12	15	33	5	14762062
Pubmed	Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-{beta}.	RBMY1D RBMY1B RBMY1E RBMY1A1	3.35e-12	5	33	4	20016065
Pubmed	An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells.	RBMY1D RBMY1B RBMY1E RBMY1A1	3.35e-12	5	33	4	8817321
Pubmed	The role of human and mouse Y chromosome genes in male infertility.	RBMY1D RBMY1B RBMY1E RBMY1A1	3.35e-12	5	33	4	11097427
Pubmed	Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability.	RBMY1D RBMY1B RBMY1E RBMY1A1	3.35e-12	5	33	4	19737860
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	BCL9L ANKRD17 ZFR TCF20 BCL9 ARID1A CREBBP AHDC1 RBMX CRTC2	9.83e-12	457	33	10	32344865
Pubmed	Identification of target messenger RNA substrates for mouse RBMY.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.01e-11	6	33	4	18492746
Pubmed	Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.01e-11	6	33	4	12356914
Pubmed	The behavior of the X- and Y-chromosomes in the oocyte during meiotic prophase in the B6.Y(TIR)sex-reversed mouse ovary.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.01e-11	6	33	4	18239052
Pubmed	Mouse homologues of the human AZF candidate gene RBM are expressed in spermatogonia and spermatids, and map to a Y chromosome deletion interval associated with a high incidence of sperm abnormalities.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.01e-11	6	33	4	9499427
Pubmed	Does Rbmy have a role in sperm development in mice?	RBMY1D RBMY1B RBMY1E RBMY1A1	1.01e-11	6	33	4	15051956
Pubmed	RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway.	RBMY1D RBMY1B RBMY1E RBMY1A1	2.35e-11	7	33	4	17001072
Pubmed	The roles of RNA-binding proteins in spermatogenesis and male infertility.	RBMY1D RBMY1B RBMY1E RBMY1A1	2.35e-11	7	33	4	10377282
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	RBMY1D RBMY1B RBMY1E COL4A3 RBMXL1 SF1 RBMX RBMY1A1 HNRNPL	2.76e-11	347	33	9	16033648
Pubmed	Y chromosome short arm-Sxr recombination in XSxr/Y males causes deletion of Rbm and XY female sex reversal.	RBMY1D RBMY1B RBMY1E RBMY1A1	4.69e-11	8	33	4	7479793
Pubmed	Mice with Y chromosome deletion and reduced Rbm genes on a heterozygous Dazl1 null background mimic a human azoospermic factor phenotype.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.40e-10	10	33	4	10601091
Pubmed	Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.40e-10	10	33	4	9384609
Pubmed	The role of Dby mRNA in early development of male mouse zygotes.	RBMY1D RBMY1B RBMY1E RBMY1A1	3.31e-10	12	33	4	20543856
Pubmed	GASZ promotes germ cell derivation from embryonic stem cells.	RBMY1D RBMY1B RBMY1E RBMY1A1	4.77e-10	13	33	4	23816659
Pubmed	Absence of mDazl produces a final block on germ cell development at meiosis.	RBMY1D RBMY1B RBMY1E RBMY1A1	6.68e-10	14	33	4	14611631
Pubmed	RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene.	RBMXL1 RBMX RBMY1A1	7.78e-10	3	33	3	10391207
Pubmed	Loss of maternal Trim28 causes male-predominant early embryonic lethality.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.58e-09	17	33	4	28115466
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	RBMY1D RBMY1B RBMY1E RBMY1A1	2.04e-09	18	33	4	12023983
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ETV5 DIDO1 ZFR TCF20 BCL9 ARID1A CREBBP AHDC1 SF1 RBMX HNRNPL	3.17e-09	1103	33	11	34189442
Pubmed	MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice.	RBMY1D RBMY1B RBMY1E RBMY1A1	9.89e-09	26	33	4	35920200
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	BCL9L TCF20 BCL9 SF1 RBMX CRTC2	1.74e-08	180	33	6	35198878
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	VPS37C DIDO1 ARHGAP39 TCF20 ARID1A RBMXL1 AHDC1 SF1 RBMX HNRNPL	3.93e-08	1082	33	10	38697112
Pubmed	Human transcription factor protein interaction networks.	ETV5 BCL9L ANKRD17 DIDO1 ZFR SSBP4 TCF20 BCL9 ARID1A CREBBP HNRNPL	4.56e-08	1429	33	11	35140242
Pubmed	T-STAR/ETOILE: a novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis.	RBMX RBMY1A1 RBMY1C	9.30e-08	10	33	3	10332027
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9L TCF20 BCL9 ARID1A CREBBP AHDC1	1.84e-07	268	33	6	33640491
Pubmed	Lineage-specific biology revealed by a finished genome assembly of the mouse.	RBMY1D RBMY1B RBMY1E RBMY1A1	2.21e-07	55	33	4	19468303
Pubmed	An abundance of X-linked genes expressed in spermatogonia.	RBMY1D RBMY1B RBMY1E RBMY1A1	2.95e-07	59	33	4	11279525
Pubmed	COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.	COL4A3 COL4A4	8.73e-07	2	33	2	24052634
Pubmed	Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.	COL4A3 COL4A4	8.73e-07	2	33	2	19357112
Pubmed	Type-IV collagen related diseases.	COL4A3 COL4A4	8.73e-07	2	33	2	12768082
Pubmed	Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis.	RBMY1B RBMY1A1	8.73e-07	2	33	2	32473614
Pubmed	Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.	COL4A3 COL4A4	8.73e-07	2	33	2	25229338
Pubmed	COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy.	COL4A3 COL4A4	8.73e-07	2	33	2	17942953
Pubmed	A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB/CRTC2 transcriptional complex.	CREBBP CRTC2	8.73e-07	2	33	2	35017472
Pubmed	Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus.	COL4A3 COL4A4	8.73e-07	2	33	2	20029656
Pubmed	Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.	COL4A3 COL4A4	8.73e-07	2	33	2	28674241
Pubmed	Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.	COL4A3 COL4A4	8.73e-07	2	33	2	16235097
Pubmed	Two genes, COL4A3 and COL4A4 coding for the human alpha3(IV) and alpha4(IV) collagen chains are arranged head-to-head on chromosome 2q36.	COL4A3 COL4A4	8.73e-07	2	33	2	9537506
Pubmed	Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney disease.	COL4A3 COL4A4	8.73e-07	2	33	2	25381091
Pubmed	Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure.	COL4A3 COL4A4	8.73e-07	2	33	2	15280517
Pubmed	Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.	COL4A3 COL4A4	8.73e-07	2	33	2	7987396
Pubmed	Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg?	COL4A3 COL4A4	8.73e-07	2	33	2	35090027
Pubmed	The genetics of thin basement membrane nephropathy.	COL4A3 COL4A4	8.73e-07	2	33	2	15880327
Pubmed	The COL4A3 and COL4A4 Digenic Mutations in cis Result in Benign Familial Hematuria in a Large Chinese Family.	COL4A3 COL4A4	8.73e-07	2	33	2	29742505
Pubmed	Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3/COL4A4?	COL4A3 COL4A4	8.73e-07	2	33	2	38214412
Pubmed	Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.	BCL9L BCL9	8.73e-07	2	33	2	20682801
Pubmed	Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.	BCL9L BCL9	8.73e-07	2	33	2	38811552
Pubmed	BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.	BCL9L BCL9	8.73e-07	2	33	2	33767438
Pubmed	Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.	COL4A3 COL4A4	8.73e-07	2	33	2	17216251
Pubmed	Heterozygous Urinary Abnormality-Causing Variants of COL4A3 and COL4A4 Affect Severity of Autosomal Recessive Alport Syndrome.	COL4A3 COL4A4	8.73e-07	2	33	2	35369551
Pubmed	Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing.	COL4A3 COL4A4	8.73e-07	2	33	2	35386907
Pubmed	COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.	COL4A3 COL4A4	8.73e-07	2	33	2	12028435
Pubmed	Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.	BCL9L BCL9	8.73e-07	2	33	2	15371335
Pubmed	Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus.	COL4A3 COL4A4	8.73e-07	2	33	2	25083577
Pubmed	Identification of the NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly.	COL4A3 COL4A4	8.73e-07	2	33	2	20847057
Pubmed	Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.	COL4A3 COL4A4	8.73e-07	2	33	2	25307543
Pubmed	COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?	COL4A3 COL4A4	8.73e-07	2	33	2	18661361
Pubmed	Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.	COL4A3 COL4A4	8.73e-07	2	33	2	27281700
Pubmed	[From Alport syndrome to benign familial hematuria: clinical and genetic aspect].	COL4A3 COL4A4	8.73e-07	2	33	2	16895672
Pubmed	How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.	COL4A3 COL4A4	8.73e-07	2	33	2	32232700
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9L TCF20 BCL9 ARID1A CREBBP AHDC1	8.91e-07	351	33	6	38297188
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	DIDO1 ZFR TCF20 ARID1A HNRNPL	1.99e-06	220	33	5	35785414
Pubmed	Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.	RBMY1D RBMY1B RBMY1E RBMY1A1	2.01e-06	95	33	4	24029230
Pubmed	Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.	COL4A3 COL4A4	2.62e-06	3	33	2	27576055
Pubmed	Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome.	COL4A3 COL4A4	2.62e-06	3	33	2	15954103
Pubmed	Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.	COL4A3 COL4A4	2.62e-06	3	33	2	36130833
Pubmed	A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.	COL4A3 COL4A4	2.62e-06	3	33	2	14507670
Pubmed	Genetic diagnosis of Alport syndrome in 16 Chinese families.	COL4A3 COL4A4	2.62e-06	3	33	2	38433557
Pubmed	Alport syndrome: impact of digenic inheritance in patients management.	COL4A3 COL4A4	2.62e-06	3	33	2	27859054
Pubmed	Evidence of digenic inheritance in Alport syndrome.	COL4A3 COL4A4	2.62e-06	3	33	2	25575550
Pubmed	Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia.	RBMXL1 RBMX	2.62e-06	3	33	2	34458856
Pubmed	Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.	COL4A3 COL4A4	2.62e-06	3	33	2	17396119
Pubmed	A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.	COL4A3 COL4A4	2.62e-06	3	33	2	24522496
Pubmed	RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet.	RBMXL1 RBMX	2.62e-06	3	33	2	17188681
Pubmed	Collagen types in various layers of the human aorta and their changes with the atherosclerotic process.	COL4A3 COL4A4	2.62e-06	3	33	2	3089234
Pubmed	Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches.	COL4A3 COL4A4	2.62e-06	3	33	2	7962065
Pubmed	Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.	COL4A3 COL4A4	2.62e-06	3	33	2	28542346
Pubmed	Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.	COL4A3 COL4A4	2.62e-06	3	33	2	28704582
Pubmed	The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.	BCL9L BCL9	2.62e-06	3	33	2	34545187
Pubmed	Differential regulation of β-catenin-mediated transcription via N- and C-terminal co-factors governs identity of murine intestinal epithelial stem cells.	BCL9L BCL9	2.62e-06	3	33	2	33649334
Pubmed	Identification of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen: implications for Alport gene therapy.	COL4A3 COL4A4	2.62e-06	3	33	2	18930919
Pubmed	Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS.	COL4A3 COL4A4	2.62e-06	3	33	2	30647093
Pubmed	CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation.	CREBBP CRTC2	2.62e-06	3	33	2	20859256
Pubmed	The candidate spermatogenesis gene RBMY has a homologue on the human X chromosome.	RBMX RBMY1A1	2.62e-06	3	33	2	10391206
Pubmed	Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome.	COL4A3 COL4A4	2.62e-06	3	33	2	38978054
Pubmed	Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 co-factor.	BCL9L BCL9	2.62e-06	3	33	2	20637214
Pubmed	hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.	RBMX RBMY1A1	2.62e-06	3	33	2	12165565
Pubmed	Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases.	COL4A3 COL4A4	2.62e-06	3	33	2	24033287
Pubmed	Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients.	COL4A3 COL4A4	2.62e-06	3	33	2	33654185
Pubmed	Characterization of assembly of recombinant type IV collagen alpha3, alpha4, and alpha5 chains in transfected cell strains.	COL4A3 COL4A4	2.62e-06	3	33	2	14633121
Interaction	TLE3 interactions	BCL9L SSBP4 TCF20 BCL9 ARID1A CREBBP AHDC1 HNRNPL CRTC2 ALG13	2.87e-10	376	33	10	int:TLE3
Interaction	RBMY1E interactions	RBMY1E RBMX RBMY1F	1.60e-08	4	33	3	int:RBMY1E
Interaction	NUP35 interactions	BCL9L ANKRD17 ZFR TCF20 BCL9 ARID1A CREBBP AHDC1 CRTC2	1.83e-08	424	33	9	int:NUP35
Interaction	RBMY1J interactions	RBMY1E RBMX RBMY1A1 RBMY1F	1.37e-07	29	33	4	int:RBMY1J
Interaction	RBMY1F interactions	RBMY1E RBMX RBMY1A1 RBMY1F	3.38e-07	36	33	4	int:RBMY1F
Interaction	ALG13 interactions	ZFR TCF20 BCL9 ARID1A SF1 ALG13	4.67e-07	183	33	6	int:ALG13
Interaction	SMG7 interactions	ANKRD17 TCF20 BCL9 ARID1A CREBBP HNRNPL ALG13	6.99e-07	319	33	7	int:SMG7
Interaction	SAA1 interactions	COL4A3 COL4A4 DIDO1 RBMXL1	1.78e-06	54	33	4	int:SAA1
Interaction	PAX9 interactions	VPS37C BCL9L TCF20 BCL9 ARID1A	2.12e-06	130	33	5	int:PAX9
Interaction	PRR3 interactions	ZFR RBMXL1 RBMX RBMY1A1 HNRNPL RBMY1F	2.62e-06	246	33	6	int:PRR3
Interaction	CEBPA interactions	ETV5 DIDO1 ZFR TCF20 BCL9 ARID1A CREBBP AHDC1 SF1 RBMX HNRNPL	2.62e-06	1245	33	11	int:CEBPA
Interaction	AR interactions	ETV5 BCL9L DIDO1 ZFR TCF20 BCL9 ARID1A CREBBP AHDC1 HNRNPL	2.62e-06	992	33	10	int:AR
Interaction	CRX interactions	VPS37C BCL9L TCF20 BCL9 ARID1A CREBBP	3.15e-06	254	33	6	int:CRX
Interaction	PCDHB14 interactions	RBMX RBMY1A1 RBMY1F	6.03e-06	22	33	3	int:PCDHB14
Interaction	RBMX interactions	RBMY1E RBMXL1 SF1 RBMX RBMY1A1 HNRNPL RBMY1F	7.99e-06	461	33	7	int:RBMX
Interaction	EGR2 interactions	BCL9L BCL9 ARID1A CREBBP AHDC1	8.12e-06	171	33	5	int:EGR2
Interaction	SP7 interactions	BCL9L ZFR TCF20 BCL9 ARID1A CREBBP	8.81e-06	304	33	6	int:SP7
Interaction	EWSR1 interactions	BCL9L ZFR TCF20 BCL9 ARID1A CREBBP SF1 RBMX HNRNPL	1.05e-05	906	33	9	int:EWSR1
Interaction	SNRPA interactions	DIDO1 ZFR SF1 RBMX RBMY1A1 HNRNPL RBMY1F	1.07e-05	482	33	7	int:SNRPA
Interaction	BCL9 interactions	BCL9L SSBP4 BCL9 ALG13	1.15e-05	86	33	4	int:BCL9
Interaction	LHX3 interactions	SSBP4 TCF20 BCL9 ARID1A CREBBP	1.19e-05	185	33	5	int:LHX3
Interaction	APOBEC3C interactions	ZFR SF1 RBMX RBMY1A1 RBMY1F	1.25e-05	187	33	5	int:APOBEC3C
Interaction	PYGO1 interactions	BCL9L SSBP4 BCL9	1.27e-05	28	33	3	int:PYGO1
Interaction	ELAVL2 interactions	ZFR RBMXL1 RBMX HNRNPL ALG13	1.29e-05	188	33	5	int:ELAVL2
Interaction	DTX2 interactions	BCL9L TCF20 BCL9 SF1 RBMX CRTC2	1.40e-05	330	33	6	int:DTX2
Interaction	FOXI1 interactions	VPS37C BCL9 ARID1A CREBBP	1.50e-05	92	33	4	int:FOXI1
Interaction	RBMY1A1 interactions	RBMX RBMY1A1 RBMY1F	1.92e-05	32	33	3	int:RBMY1A1
Interaction	MECP2 interactions	VPS37C DIDO1 ARHGAP39 TCF20 ARID1A RBMXL1 AHDC1 SF1 RBMX HNRNPL	2.60e-05	1287	33	10	int:MECP2
Interaction	CLK3 interactions	ZFR RBMXL1 RBMX RBMY1A1 RBMY1F	2.74e-05	220	33	5	int:CLK3
Interaction	KLF1 interactions	VPS37C ARID1A CREBBP	2.99e-05	37	33	3	int:KLF1
Interaction	LDB1 interactions	BCL9L SSBP4 BCL9 HNRNPL	3.62e-05	115	33	4	int:LDB1
Interaction	TBXT interactions	TCF20 BCL9 ARID1A CREBBP	3.75e-05	116	33	4	int:TBXT
Interaction	ISL1 interactions	BCL9L SSBP4 BCL9	4.09e-05	41	33	3	int:ISL1
Interaction	ISL2 interactions	BCL9L SSBP4 BCL9	4.09e-05	41	33	3	int:ISL2
Interaction	SSBP3 interactions	BCL9L SSBP4 BCL9 HNRNPL	4.14e-05	119	33	4	int:SSBP3
Interaction	DCN interactions	COL4A3 COL4A4 SF1	4.72e-05	43	33	3	int:DCN
Interaction	WWP2 interactions	VPS37C ANKRD17 DIDO1 ARID1A AHDC1 SF1 RBMX HNRNPL	4.83e-05	840	33	8	int:WWP2
Interaction	PAX7 interactions	SSBP4 BCL9 ARID1A CREBBP	4.87e-05	124	33	4	int:PAX7
Interaction	EP300 interactions	ETV5 ZFR SSBP4 ARID1A CREBBP SF1 RBMX HNRNPL CRTC2 ALG13	5.38e-05	1401	33	10	int:EP300
Interaction	SNRNP40 interactions	BCL9L TCF20 BCL9 ARID1A AHDC1 RBMX HNRNPL	6.36e-05	637	33	7	int:SNRNP40
Interaction	PYGO2 interactions	BCL9L BCL9 CREBBP	6.58e-05	48	33	3	int:PYGO2
Interaction	BCL9L interactions	BCL9L SSBP4 BCL9	6.58e-05	48	33	3	int:BCL9L
Interaction	NFIB interactions	BCL9 ARID1A CREBBP HNRNPL	8.25e-05	142	33	4	int:NFIB
Interaction	RC3H2 interactions	ANKRD17 ZFR SF1 RBMX HNRNPL CRTC2 ALG13	8.50e-05	667	33	7	int:RC3H2
Interaction	DAZL interactions	ANKRD17 SF1 HNRNPL ALG13	8.94e-05	145	33	4	int:DAZL
Interaction	APOBEC3D interactions	ZFR RBMXL1 RBMX HNRNPL	9.68e-05	148	33	4	int:APOBEC3D
Interaction	CELF1 interactions	ZFR SF1 RBMX HNRNPL ALG13	9.84e-05	288	33	5	int:CELF1
Interaction	LHX6 interactions	BCL9L SSBP4 BCL9	1.16e-04	58	33	3	int:LHX6
Interaction	SSBP4 interactions	BCL9L SSBP4 BCL9	1.22e-04	59	33	3	int:SSBP4
Interaction	SF1 interactions	ZFR SF1 RBMX HNRNPL ALG13	1.27e-04	304	33	5	int:SF1
Interaction	HOXB6 interactions	ANKRD17 CREBBP HNRNPL	1.28e-04	60	33	3	int:HOXB6
Interaction	KLF4 interactions	ZFR BCL9 ARID1A CREBBP	1.31e-04	160	33	4	int:KLF4
Interaction	CIRBP interactions	SF1 RBMX RBMY1A1 RBMY1F	1.44e-04	164	33	4	int:CIRBP
Interaction	LHX4 interactions	BCL9L SSBP4 BCL9 ARID1A	1.51e-04	166	33	4	int:LHX4
Interaction	GATA1 interactions	ZFR BCL9 ARID1A CREBBP	1.69e-04	171	33	4	int:GATA1
Interaction	FRMPD2 interactions	VPS37C HNRNPL	1.70e-04	12	33	2	int:FRMPD2
Interaction	TLX1 interactions	TCF20 BCL9 ARID1A CREBBP	1.85e-04	175	33	4	int:TLX1
Interaction	GCM1 interactions	BCL9 ARID1A CREBBP	1.86e-04	68	33	3	int:GCM1
Interaction	FUS interactions	DIDO1 ZFR ARID1A CREBBP SF1 RBMX HNRNPL	1.87e-04	757	33	7	int:FUS
Interaction	CPSF6 interactions	DIDO1 ZFR CREBBP RBMX HNRNPL ALG13	1.87e-04	526	33	6	int:CPSF6
Interaction	ETV4 interactions	BCL9 ARID1A CREBBP	1.95e-04	69	33	3	int:ETV4
Interaction	MEN1 interactions	ANKRD17 DIDO1 ZFR TCF20 ARID1A AHDC1 SF1 RBMX	1.99e-04	1029	33	8	int:MEN1
Interaction	PLOD2 interactions	COL10A1 TCF20 SF1 RBMX	2.06e-04	180	33	4	int:PLOD2
Interaction	FMR1 interactions	ANKRD17 ZFR TCF20 BCL9 HNRNPL ALG13	2.07e-04	536	33	6	int:FMR1
Interaction	LHX2 interactions	BCL9L SSBP4 BCL9 ARID1A	2.19e-04	183	33	4	int:LHX2
Interaction	GATA3 interactions	ZFR BCL9 ARID1A CREBBP	2.38e-04	187	33	4	int:GATA3
Interaction	FAM120A interactions	ZFR RBMXL1 RBMX HNRNPL ALG13	2.41e-04	349	33	5	int:FAM120A
Interaction	NFIA interactions	BCL9 ARID1A CREBBP HNRNPL	2.43e-04	188	33	4	int:NFIA
Interaction	MYCN interactions	ANKRD17 DIDO1 ZFR TCF20 ARID1A RBMXL1 SF1 RBMX HNRNPL	2.66e-04	1373	33	9	int:MYCN
Interaction	RAMAC interactions	VPS37C RBMX RBMY1F	3.24e-04	82	33	3	int:RAMAC
Interaction	SOX7 interactions	TCF20 ARID1A CREBBP	3.24e-04	82	33	3	int:SOX7
Interaction	FEV interactions	TCF20 BCL9 ARID1A CREBBP	3.25e-04	203	33	4	int:FEV
Interaction	RBM47 interactions	ZFR RBMXL1 HNRNPL ALG13	3.31e-04	204	33	4	int:RBM47
Interaction	TRA2B interactions	RBMX RBMY1A1 HNRNPL RBMY1F ALG13	3.79e-04	385	33	5	int:TRA2B
Interaction	GSC interactions	BCL9L BCL9 CREBBP	3.86e-04	87	33	3	int:GSC
Interaction	HABP2 interactions	COL4A3 COL4A4	3.91e-04	18	33	2	int:HABP2
Interaction	PEA15 interactions	DIDO1 RBMXL1 HNRNPL	4.26e-04	90	33	3	int:PEA15
Interaction	CAPN13 interactions	DIDO1 SF1	4.37e-04	19	33	2	int:CAPN13
Interaction	NUCKS1 interactions	DIDO1 TCF20 ARID1A RBMX	4.41e-04	220	33	4	int:NUCKS1
Interaction	MIR155 interactions	ZFR SF1 HNRNPL	4.55e-04	92	33	3	int:MIR155
Interaction	ERG interactions	TCF20 BCL9 ARID1A CREBBP	4.64e-04	223	33	4	int:ERG
Interaction	NUP43 interactions	BCL9L TCF20 ARID1A AHDC1 RBMX GUCY2D	4.71e-04	625	33	6	int:NUP43
Interaction	MIR19B2 interactions	ZFR SF1 HNRNPL	4.84e-04	94	33	3	int:MIR19B2
Interaction	LHX9 interactions	ANKRD17 SSBP4	4.85e-04	20	33	2	int:LHX9
Interaction	OSM interactions	COL4A3 COL4A4	4.85e-04	20	33	2	int:OSM
Interaction	SOX17 interactions	TCF20 BCL9 ARID1A	5.00e-04	95	33	3	int:SOX17
Interaction	LINC02910 interactions	DIDO1 RBMXL1 HNRNPL	5.00e-04	95	33	3	int:LINC02910
Interaction	HNRNPC interactions	ZFR ARID1A RBMXL1 SF1 RBMX HNRNPL	5.08e-04	634	33	6	int:HNRNPC
Interaction	SOX9 interactions	BCL9 ARID1A CREBBP	5.31e-04	97	33	3	int:SOX9
Interaction	MIR106B interactions	ZFR SF1 HNRNPL	5.47e-04	98	33	3	int:MIR106B
Interaction	POLR2J3 interactions	VPS37C HNRNPL	5.88e-04	22	33	2	int:POLR2J3
Interaction	LARP4B interactions	ANKRD17 ZFR RBMXL1 ALG13	6.12e-04	240	33	4	int:LARP4B
Interaction	LHX1 interactions	SSBP4 BCL9 ARID1A	6.33e-04	103	33	3	int:LHX1
Interaction	USP48 interactions	DIDO1 ZFR SF1 RBMX HNRNPL GUCY2D	6.69e-04	668	33	6	int:USP48
Interaction	SSBP2 interactions	BCL9L SSBP4 BCL9	6.69e-04	105	33	3	int:SSBP2
Interaction	SNRPC interactions	DIDO1 ZFR RBMXL1 RBMX HNRNPL	6.95e-04	440	33	5	int:SNRPC
Interaction	TFAP2B interactions	SSBP4 CREBBP	7.02e-04	24	33	2	int:TFAP2B
Interaction	MFHAS1 interactions	ETV5 AHDC1 CRTC2	7.07e-04	107	33	3	int:MFHAS1
Interaction	RC3H1 interactions	ANKRD17 ZFR SF1 RBMX HNRNPL ALG13	7.17e-04	677	33	6	int:RC3H1
Interaction	RBMS2 interactions	ZFR RBMXL1 HNRNPL ALG13	7.24e-04	251	33	4	int:RBMS2
Cytoband	Yq11.223	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	6.94e-09	93	33	5	Yq11.223
Cytoband	Ensembl 112 genes in cytogenetic band chrYq11	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	2.81e-06	311	33	5	chrYq11
Cytoband	11q23.3	BCL9L TBCEL	1.45e-03	78	33	2	11q23.3
Cytoband	Ensembl 112 genes in cytogenetic band chr2q36	COL4A3 COL4A4	1.72e-03	85	33	2	chr2q36
GeneFamily	RNA binding motif containing	RBMY1D RBMY1B RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C HNRNPL RBMY1F	4.14e-12	213	24	9	725
GeneFamily	Collagens	COL4A3 COL4A4 COL10A1	3.00e-05	46	24	3	490
Coexpression	CHEN_ETV5_TARGETS_TESTIS	RBMY1D RBMY1B RBMY1E RBMY1A1	7.30e-08	33	32	4	MM701
Coexpression	ZHENG_IL22_SIGNALING_DN	RBMY1D RBMY1B RBMY1E RBMY1A1	2.63e-07	45	32	4	MM763
Coexpression	NABA_COLLAGENS	COL4A3 COL4A4 COL10A1	1.97e-05	43	32	3	MM17060
Coexpression	NABA_COLLAGENS	COL4A3 COL4A4 COL10A1	2.12e-05	44	32	3	M3005
Coexpression	BASAKI_YBX1_TARGETS_DN	ETV5 SSBP4 RBMXL1 SF1 ALG13	1.13e-04	398	32	5	M14877
ToppCell	PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL4A3 DIDO1 AHDC1	1.06e-04	137	30	3	ed81624b9167255ce88dcf6ad7f1636376ea0525
ToppCell	PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL4A3 DIDO1 AHDC1	1.06e-04	137	30	3	47859aa25f32367461c1ec75ed9060bee430c6b7
ToppCell	Epithelial-B_(AT1-AT2-progenitors)\|World / shred on cell class and cell subclass (v4)	COL4A3 COL4A4 ETV5	1.27e-04	146	30	3	4511916904c1fac252cb68e871b782207f8137b3
ToppCell	normal-na-Lymphocytic_B-B_plasma-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	COL4A3 COL4A4 GUCY2D	2.00e-04	170	30	3	c5b87974dfddf9780051f7f5693eeeb0c606a3fe
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.10e-04	173	30	3	45808cf69122c16b9d2b5ffa06d15392c55954b7
ToppCell	P07-Epithelial\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A3 COL4A4 ETV5	2.10e-04	173	30	3	8b10087a917b825809d35a2b2b349c73a2782472
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.10e-04	173	30	3	7fa9dbcb258c3ab974490063951620e2def03db1
ToppCell	P07-Epithelial-alveolar_epithelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A3 COL4A4 ETV5	2.14e-04	174	30	3	2739de68e0266054694f99807cfb1f07b6bbb371
ToppCell	P15-Epithelial\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A3 COL4A4 ETV5	2.32e-04	179	30	3	869d3d203e2cb88636e2f0c4476c72571ae3b5ca
ToppCell	BAL-Severe-Lymphocyte-B-B_cell\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A3 COL4A4 TCF20	2.36e-04	180	30	3	c3c72531af5b9f7a7416727fe609dab5180e03b6
ToppCell	BAL-Severe-Lymphocyte-B-B_cell-B_cell\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A3 COL4A4 TCF20	2.36e-04	180	30	3	b465f2f8b0e9a2034a4f1272bb00c77439164dbf
ToppCell	BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A3 COL4A4 TCF20	2.36e-04	180	30	3	9f4bbaf6435c23e3e552ae22be8ea7884314192d
ToppCell	P15-Epithelial-alveolar_epithelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A3 COL4A4 ETV5	2.40e-04	181	30	3	7033be0ba90556f7e5f7c0d4a9f7644afcb22c9b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 COL4A4 ETV5	2.40e-04	181	30	3	22363c5835dd6cef8f895ab9362e0837d92b15b1
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A3 COL4A4 ETV5	2.44e-04	182	30	3	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	P28-Epithelial\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A3 COL4A4 ETV5	2.52e-04	184	30	3	05811d13bd8a602095a3fcf5e55345edadc7b8bf
ToppCell	IIF-Lymphocyte-B-B_memory\|IIF / Disease, Lineage and Cell Type	COL4A3 COL4A4 SSBP4	2.56e-04	185	30	3	c0eeab45c4ddefe107690a4ba8868fed2962c730
ToppCell	PND01-03-samps-Epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	COL4A3 COL4A4 ETV5	2.56e-04	185	30	3	2b854df79cfe2cb4d2f9c2938a066e0aa3649325
ToppCell	P28-Epithelial-alveolar_epithelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A3 COL4A4 ETV5	2.56e-04	185	30	3	5bb513e569f3a197d55ae2ca683e202daebabeac
ToppCell	E17.5-Epithelial-alveolar_epithelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A3 COL4A4 ETV5	2.60e-04	186	30	3	a7a2ef8392a045a62fa4d0983577711d5d397dc4
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	COL4A3 COL4A4 ETV5	2.64e-04	187	30	3	23fe3cdd6cc9b067086a8392d104186d300298ea
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A3 COL4A4 ETV5	2.68e-04	188	30	3	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	COL4A3 COL4A4 ALG13	2.72e-04	189	30	3	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	PND10-Epithelial-Epithelial_Alveolar\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.77e-04	190	30	3	dc20d323cee2741e39fba597263d6418ae0eadaf
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.77e-04	190	30	3	ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab
ToppCell	PND07-Epithelial-Epithelial_Alveolar\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.77e-04	190	30	3	ee39fb88f31d2d65b5d3e7416db68f5df07f6637
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.77e-04	190	30	3	33d1b0a38267270e87702ba5794f07233acf4955
ToppCell	Epithelial\|World / shred on cell class and cell subclass (v4)	COL4A3 COL4A4 ETV5	2.85e-04	192	30	3	13a3553d9a7c78535679d23d454c63fd08f7d218
ToppCell	PND03-Epithelial-Epithelial_Alveolar\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.90e-04	193	30	3	5dfa69a680a0859900141c40a446d217aaa747d3
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.90e-04	193	30	3	ebea35704ac5d21e947ae094313cf2a5205e7014
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	COL4A3 COL4A4 ALG13	2.94e-04	194	30	3	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	PND01-Epithelial\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.94e-04	194	30	3	d21db5e942966ed44bc78ff50130a201fc627074
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL4A3 COL4A4 ETV5	2.99e-04	195	30	3	0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.99e-04	195	30	3	43164511f32e4591cb5399182fbac0b911716233
ToppCell	PND01-Epithelial-Epithelial_Alveolar\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4 ETV5	2.99e-04	195	30	3	9337111d75a487abc02969337718c30b1fe81379
ToppCell	COVID-19_Severe-B_memory\|COVID-19_Severe / disease group, cell group and cell class	COL4A3 COL4A4 SF1	2.99e-04	195	30	3	54becd9e283639638fc5f13eddce224aed9391da
ToppCell	severe_COVID-19-B_intermediate\|severe_COVID-19 / disease group, cell group and cell class (v2)	COL4A3 COL4A4 SF1	3.08e-04	197	30	3	3ba64850b344cb24a4d20d64392a0b2752950d40
ToppCell	MS-IIF-Lymphocyte-B-B_memory\|IIF / Disease, condition lineage and cell class	COL4A3 COL4A4 SSBP4	3.12e-04	198	30	3	ae6f1d3ca7d7aa6f6f45b6b51aa8a967cadde017
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL4A3 COL4A4 ETV5	3.12e-04	198	30	3	1851b7f4198b42c21c934e2fbda39dbd65e2625c
ToppCell	Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	1.48e-03	85	30	2	5a2c02aeceeabd44a417b09ac8b2e2f185070b15
ToppCell	Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	1.48e-03	85	30	2	7c5ea38893372fdecf7cc3ccf46a37b4ec45f0b1
ToppCell	Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	1.48e-03	85	30	2	0bfabb6761a84d6a04f9fa415106a33059d78099
ToppCell	Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	2.12e-03	102	30	2	72ce247dad7404e6b9c971b5c29d3c6846da5efc
ToppCell	Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	2.12e-03	102	30	2	8c4d9483ff983538593f4e17f4a74a93cdda59c4
ToppCell	Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	2.12e-03	102	30	2	5feedce6d26a578c4aaba4e4824b3d0c3f3806bc
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A3 COL4A4	2.38e-03	108	30	2	d620f07243c2628494e689bbfabc14c453f4b1f4
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	2.60e-03	113	30	2	0651fb7a7e1ea84b8365059e5ed85bf6c082da1a
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	2.60e-03	113	30	2	0e153efddd061d7510dfc3859cc8b1a7984fa70e
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	2.97e-03	121	30	2	c96115bd33455296378a257583b49442d00b39ca
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	2.97e-03	121	30	2	5035e071033cb76a7fc0128716755b14821e8f05
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	VPS37C GUCY2D	2.97e-03	121	30	2	e57b026794130aa69b67f6170bcd5093f885fdb1
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-AT2_progenitor\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ETV5 VPS37C	3.17e-03	125	30	2	b5fed0e0295aa8ad323c318b59bf23cde3e758c8
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-AT1\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL4A3 COL4A4	3.42e-03	130	30	2	eb16a8f8f62add5fdd29c78d4608b6d1a06767f1
ToppCell	TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3\|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9	DIDO1 TBCEL	3.68e-03	135	30	2	ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	RBMXL1 RBMY1A1	3.68e-03	135	30	2	b128596653a5e3b64ed7f657bbfeda35438e2e48
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	3.79e-03	137	30	2	9324b55eac55e0cc1e8e450a4b5374d12e9587a3
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	3.79e-03	137	30	2	032f8409d0d179e254c8ff632afbda78852a9889
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	COL4A3 COL4A4	3.79e-03	137	30	2	265a4a50e48b13c8b3b0730f818235f71fbd6baa
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	ANKRD17 ZFR	3.84e-03	138	30	2	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	356C-Epithelial_cells-Epithelial-B_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BCL9L C2CD4A	3.90e-03	139	30	2	aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c
ToppCell	356C-Epithelial_cells-Epithelial-B_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BCL9L C2CD4A	3.90e-03	139	30	2	b9c2dfab119ac0efdf931bb2910e82bccdb4e48d
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A3 COL4A4	3.90e-03	139	30	2	693ca81f5831b63fe6148ac755631e09f67d0ebf
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-AT1_-_meso\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL4A3 COL4A4	4.06e-03	142	30	2	77fd145c1c500d580f70ac4e54c3fd879ecf0ab3
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	TCF20 AHDC1	4.17e-03	144	30	2	57d2846ec26d4490ec11c171af447b17a729437e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 ETV5	4.23e-03	145	30	2	b961b69befb15ff6f58635e0d4bda88ea732a346
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 COL4A4	4.23e-03	145	30	2	8da10bc6611976e1ec85e09f04a2dc5bf6555c9e
ToppCell	E16.5-samps\|World / Age Group, Lineage, Cell class and subclass	RBMXL1 AHDC1	4.46e-03	149	30	2	e94d075f68c1c70c89fab50b1b765b5dda650d09
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial-AT1_-_meso\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	COL4A3 COL4A4	4.52e-03	150	30	2	6a13e4c4b9c9e54a5016573a37132465ec1c8f99
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A3 COL4A4	4.52e-03	150	30	2	4bdcdce40f54580c7a4e1416b468e657ba8874fc
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	COL4A3 GUCY2D	4.58e-03	151	30	2	0b6b37734430918378ed94e40877f0c4ae9b25ec
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A3 GUCY2D	4.58e-03	151	30	2	30225a1a7800b0ae19e16ac164f561379eedb99d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 COL4A4	4.58e-03	151	30	2	16fc903fc71e25717b9908416f0bcd29c0a65a61
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	C2CD4A TBCEL	4.64e-03	152	30	2	eb7ff36792c3c54ac88cfe976f84016b70b1a1d7
ToppCell	P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A3 COL4A4	4.70e-03	153	30	2	5501095bcf73080872ae01128f21399f9cfc5dd1
ToppCell	Epithelial-Epithelial-B_(AT1-AT2-progenitors)\|Epithelial / shred on cell class and cell subclass (v4)	ETV5 ANKRD17	4.75e-03	154	30	2	770712806e26f73456fb77a81aa4ef8ec78a21ea
ToppCell	AT1-AT2_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	COL4A3 COL4A4	4.82e-03	155	30	2	010e45ef4b505bf419ea41e4d1619521d1c78319
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A3 COL4A4	4.82e-03	155	30	2	881422c57d230c0e2e5f9098ab888caa94ca61aa
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 COL4A4	4.88e-03	156	30	2	4d2679e7639758c49fc25a2deb9109b08f0a3e57
ToppCell	368C-Myeloid-Monocyte-CD16+_Monocyte\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL4A3 RBMXL1	4.88e-03	156	30	2	25b0936960be4955b6a6d6b8a867fdd4be548f05
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1\|TCGA-Thryoid / Sample_Type by Project: Shred V9	C2CD4A COL10A1	4.88e-03	156	30	2	45a05c7a45a3ec8551818ab67f18b3b9553934c1
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A3 COL4A4	4.88e-03	156	30	2	4e4b94580969a9736ca28df79715535a4bd1f9b2
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-3\|TCGA-Endometrium / Sample_Type by Project: Shred V9	COL4A3 COL4A4	4.94e-03	157	30	2	ef70abc999be3a2c1eed7d21aef4b484f69d8567
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A3 COL4A4	4.94e-03	157	30	2	9665a1375cfd8e9b8781c852686591226c0e0d9a
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 COL10A1	5.00e-03	158	30	2	e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 COL10A1	5.00e-03	158	30	2	12661763d1c309106801cb710c04cd2b62d16cba
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 COL10A1	5.00e-03	158	30	2	0792c39e6fc0745095af7812de2d50949540d60f
ToppCell	10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory\|Lung / Manually curated celltypes from each tissue	COL4A3 COL4A4	5.06e-03	159	30	2	d3202ddc291b8686dbe67690df13c7daffec2199
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	COL4A3 COL4A4	5.12e-03	160	30	2	58ed3a074932ccc951e07868dfdc61b99ae1cc2b
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A3 COL4A4	5.18e-03	161	30	2	1e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A3 COL4A4	5.18e-03	161	30	2	63f0b97c741b610c450f65fa5764d712bfe09ce8
ToppCell	368C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	COL4A4 ARHGAP39	5.18e-03	161	30	2	1011094c54381d52566e24c92f89f2efc2aa3eea
ToppCell	normal-na-Lymphocytic_B-B_cell-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	COL4A4 ARHGAP39	5.25e-03	162	30	2	ae292318d339305932457bb0e91430594f7a3dfa
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4	5.25e-03	162	30	2	d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A3 COL4A4	5.25e-03	162	30	2	06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3
ToppCell	normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th\|normal_Lymph_Node / Location, Cell class and cell subclass	C2CD4A SSBP4	5.25e-03	162	30	2	12bd0b99aee13da60d0684a5e2a705824db1899c
ToppCell	AT1_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	COL4A3 COL4A4	5.25e-03	162	30	2	ae2ba4f21f6f6c512006fa531d670b88be7c04c9
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A3 COL4A4	5.25e-03	162	30	2	8278dccdb139396ede34b83b02ebce837f2489d6
ToppCell	AT1-AT2_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	COL4A3 COL4A4	5.25e-03	162	30	2	57d627259d27f39885bf416d74bcb6656db6e27b
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory\|bone_marrow / Manually curated celltypes from each tissue	COL4A3 COL4A4	5.31e-03	163	30	2	30f5c93c4e170304d701b5231f0d545f404066f7
ToppCell	Basal_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	C2CD4A AHDC1	5.31e-03	163	30	2	679e25e5548d157d49a73057a3b5617dccda260f
Drug	azafagomine	RBMY1D RBMY1B RBMY1E RBMX RBMY1A1	1.57e-08	57	32	5	CID011957435
Drug	hydantoin-5-propionic acid	RBMY1D RBMY1B RBMY1E RBMY1A1	1.89e-08	21	32	4	CID000000782
Drug	AZFd	RBMY1D RBMY1B RBMY1E RBMY1A1	2.79e-08	23	32	4	CID000196489
Drug	Vistar	RBMY1D RBMY1B RBMY1E RBMY1A1	1.83e-07	36	32	4	CID000040896
Drug	2-chlorodideoxyadenosine	RBMY1D RBMY1B RBMY1E RBMY1A1	3.82e-07	43	32	4	CID000072194
Drug	PKI166	RBMY1D RBMY1B RBMY1E RBMY1A1	5.99e-07	48	32	4	CID006918403
Drug	HgCl	RBMY1D RBMY1B RBMY1E RBMY1A1	6.51e-07	49	32	4	CID000024182
Drug	thioglycolate	RBMY1D RBMY1B RBMY1E RBMY1A1	2.31e-06	67	32	4	CID000001133
Drug	SU6668	RBMY1D RBMY1B RBMY1E RBMY1A1	2.76e-06	70	32	4	CID000206042
Drug	p11-13	RBMY1D RBMY1B RBMY1E RBMY1A1	3.64e-06	75	32	4	CID000015759
Drug	CP-331	COL4A3 COL10A1	5.74e-06	3	32	2	CID000130967
Drug	bipy	RBMY1D RBMY1B RBMY1E RBMY1A1	1.02e-05	97	32	4	CID000001474
Drug	2-oyl	RBMY1D RBMY1B RBMY1E RBMY1A1	1.39e-05	105	32	4	CID000657137
Drug	carbonyl sulfide	RBMY1D RBMY1B RBMY1E RBMY1A1	2.06e-05	116	32	4	CID000010039
Drug	glutamin	RBMY1D RBMY1B RBMY1E ARID1A CREBBP RBMY1A1	3.87e-05	461	32	6	CID000000738
Drug	oligoadenylate	RBMY1D RBMY1B RBMY1E RBMY1A1	6.73e-05	157	32	4	CID000107918
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	DIDO1 ZFR ARID1A CREBBP	1.17e-04	181	32	4	6951_DN
Drug	Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	COL4A3 ETV5 COL10A1 ARID1A	1.49e-04	193	32	4	3347_UP
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A	ZFR SF1 HNRNPL TBCEL	1.52e-04	194	32	4	4319_DN
Drug	Nadide [53-84-9]; Up 200; 6uM; HL60; HT_HG-U133A	COL10A1 ARID1A CREBBP TBCEL	1.55e-04	195	32	4	2529_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	COL4A3 ETV5 CREBBP GUCY2D	1.59e-04	196	32	4	6060_UP
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A	ETV5 ZFR BCL9 ALG13	1.62e-04	197	32	4	2060_DN
Disease	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE	COL4A3 COL4A4	8.06e-07	2	27	2	C4746745
Disease	benign familial hematuria (is_implicated_in)	COL4A3 COL4A4	8.06e-07	2	27	2	DOID:0111365 (is_implicated_in)
Disease	autosomal recessive Alport syndrome (is_implicated_in)	COL4A3 COL4A4	8.06e-07	2	27	2	DOID:0110033 (is_implicated_in)
Disease	Alport syndrome, recessive type	COL4A3 COL4A4	8.06e-07	2	27	2	C2931254
Disease	Alport syndrome, dominant type	COL4A3 COL4A4	8.06e-07	2	27	2	C2931253
Disease	Thin basement membrane disease	COL4A3 COL4A4	8.06e-07	2	27	2	C0403440
Disease	Benign familial hematuria	COL4A3 COL4A4	8.06e-07	2	27	2	cv:C0241908
Disease	Renal glomerular disease	COL4A3 COL4A4 CREBBP	1.20e-06	23	27	3	C0268731
Disease	Glomerulopathy Assessment	COL4A3 COL4A4 CREBBP	1.20e-06	23	27	3	C4521256
Disease	Alport syndrome	COL4A3 COL4A4	2.42e-06	3	27	2	cv:C1567741
Disease	autosomal recessive Alport syndrome (implicated_via_orthology)	COL4A3 COL4A4	2.42e-06	3	27	2	DOID:0110033 (implicated_via_orthology)
Disease	Collagen IV-related nephropathies	COL4A3 COL4A4	2.42e-06	3	27	2	cv:CN076135
Disease	Hematuria, Benign Familial	COL4A3 COL4A4	4.83e-06	4	27	2	C0241908
Disease	Alport Syndrome	COL4A3 COL4A4	4.83e-06	4	27	2	C1567741
Disease	Alport Syndrome, X-Linked	COL4A3 COL4A4	8.05e-06	5	27	2	C1567742
Disease	Alport Syndrome, Autosomal Dominant	COL4A3 COL4A4	8.05e-06	5	27	2	C1567743
Disease	Alport Syndrome, Autosomal Recessive	COL4A3 COL4A4	8.05e-06	5	27	2	C1567744
Disease	hypertensive nephropathy	COL4A3 COL4A4	1.21e-05	6	27	2	C0848548
Disease	collagen disease (implicated_via_orthology)	COL4A3 COL4A4	5.29e-05	12	27	2	DOID:854 (implicated_via_orthology)
Disease	refractive error	COL4A3 COL4A4 COL10A1 GUCY2D	2.10e-04	326	27	4	MONDO_0004892
Disease	Sezary Syndrome	ARID1A CREBBP	2.79e-04	27	27	2	C0036920
Disease	end stage renal disease (is_implicated_in)	COL4A3 COL4A4	6.47e-04	41	27	2	DOID:783 (is_implicated_in)
Disease	Carcinoma, Transitional Cell	ARID1A CREBBP	6.47e-04	41	27	2	C0007138
Disease	myopathy (implicated_via_orthology)	COL4A3 COL4A4	8.86e-04	48	27	2	DOID:423 (implicated_via_orthology)
Disease	pre-eclampsia (is_marker_for)	ARID1A CREBBP	1.29e-03	58	27	2	DOID:10591 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
HPSPRQGRGYGMPRN	ALG13	646	Q9NP73
PGHQGEMGPLGQRGY	COL4A3	861	Q01955
AGRGRGAGMPYPTPA	CREBBP	216	Q92793
RGEPGRYGPPGFHRG	COL4A4	1001	P53420
YPGFMPQAHPGLGGG	AHDC1	1566	Q5TGY3
MYGPGAPLGGAPAAA	ANKRD17	2351	O75179
HGAPPARGPRMSYGG	RBMY1A1	401	P0DJD3
HGAPPARGPRMSYGG	RBMY1B	401	A6NDE4
HGAPPARGPRMSYGG	RBMY1C	401	P0DJD4
HGAPPARGPRMSYGG	RBMY1D	401	P0C7P1
RYGTAHGAPPARGPR	RBMY1E	396	A6NEQ0
HGAPPARGPRMSYGG	RBMY1E	401	A6NEQ0
HGAPPARGPRMSYGG	RBMY1F	401	Q15415
GPPSRGGHMDDGGYS	RBMX	121	P38159
RAGPRHKYAPNPGGG	ARHGAP39	411	Q9C0H5
GAGGQMHGQPGIPPY	ARID1A	836	O14497
GTRMHFPRGGSAPGP	GUCY2D	431	Q02846
MGGHRMFPGPLRGPA	EXOC3-AS1	86	Q8N2X6
YEHGVPGMPGPPAHG	ETV5	271	P41161
RGMGLGPGYDAPGLH	CRTC2	321	Q53ET0
AGLYTHPGPVGSPGM	BCL9	1366	O00512
AGRMGDAYPPGVLPG	BCL9L	1286	Q86UU0
LGMSGLHGPNFPGPR	DIDO1	1761	Q9BTC0
GPPVGGHRRGPSRYG	HNRNPL	346	P14866
PAPRPRAHTYGGGGG	C2CD4A	126	Q8NCU7
GPPSRGGHMDDGGYS	RBMXL1	121	Q96E39
PLGMHGPAGYPAHGP	NKX1-1	396	Q15270
MGYGAPGRPGERGLP	COL10A1	191	Q03692
GPHGQPFMSPRFPGG	SSBP4	141	Q9BWG4
GRSRGPGGDPHHMNP	TCF20	1021	Q9UGU0
RRRMPDGGYPHGPPG	ZFR	681	Q96KR1
PMGASGPGYPLRGGR	VPS37C	276	A5D8V6
SRPYHGMHGGGPGGP	SF1	376	Q15637
NFPYRRGPGMGVHVP	TBCEL	21	Q5QJ74